Phase 1 Rhythm Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Rocket Pharmaceuticals Inc.9 enrolled3 locationsNCT05885412
Recruiting
Phase 1
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Arrhythmogenic Right Ventricular Cardiomyopathy
Tenaya Therapeutics15 enrolled7 locationsNCT06228924
Not Yet Recruiting
Phase 1
Antiarrhythmic effects of phenytoin or dantrolene in patients with cardiomyopathy.
CardiomyopathyArrhythmia
University of Newcastle105 enrolled1 locationACTRN12619000730101
Suspended
Phase 1
A Phase I Study of Nifekalant in Healthy Chinese Male Volunteers.
Arrhythmias
Fuwai hospital36 enrolled1 locationACTRN12616000034437